Care Denials Rise as CMS Halts Medicare Advantage Rule Changes
The recent suspension of new Medicare Advantage prior authorization transparency rules by the Centers for Medicare & Medicaid Services (CMS) signals critical implications for revenue cycle management (RCM) teams. With growing public concern regarding care denials, RCM professionals must prepare for shifting operational dynamics in how they handle prior authorizations and denials moving forward.
What's Actually Happening
The CMS has decided to pause the implementation of new transparency rules related to prior authorization in Medicare Advantage plans. This decision comes amid escalating public outcry regarding the increasing rate of care denials linked to prior authorization processes. Stakeholders have raised concerns that these administrative hurdles can significantly impede patient access to necessary services. The transparency rules were designed to shed light on the prior authorization process, thereby fostering accountability and reducing denials. However, the suspension reflects the complexities and pushback involved in reforming these practices in the Medicare Advantage landscape.
Free Daily RCM Intelligence
Denial trends, payer policy moves, vendor intel — delivered every morning. Free.